HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS CONFERENCE CALENDAR
LATEST UPDATES » Vol 20, No 12, December 2016 – Medical Imaging Technology       » Climate Change Could Hurt Coffee, Help Banana Production       » Partnerships and Innovation: Shaping the Future of Healthcare in Asia Pacific       » Chugai's Novel Antibody Technologies Put Singapore at the Centre of Fight Against Disease       » NUS Scientists Discover the "Switch" that Makes Breast Cancer Cells Aggressive      
BIOBOARD - KOREA
STC life, Ltd. successfully treats stroke patients at Stem Cell Research Treatment Center
The Stem Cell Research Institute of STC Life Co., Ltd. and the 97.7 B&H Clinic in Korea have successfully completed mesenchymal stem cell treatment for stroke patients.

Stroke is a disorder of partial or overall brain function that lasts for a considerable period of time, its causes, other than cerebrovascular disease, has not been found. Stroke is a general term for disease caused by cerebrovascular disorders, commonly refers to the cerebrovascular disease due to sudden circulatory disorder of brain blood vessels. This causes the loss of consciousness and paralysis of a body. Stroke occurs due to sudden neurological dysfunction regardless of causes. Symptoms include headache, vomiting, hemiplegia, or partial paralysis of body, sensory paralysis (or loss) of body part.

Researchers from 97.7 B & H Clinic intravenously injected stem cells to stroke patients five times at intervals of two weeks. Mesenchymal stem cells, one of the adult stem cells, are widely used for tissue regeneration. Researchers in the Stem Cell Research Treatment Center then gathered and used some stem cells from fetal umbilical cord.

Patients who received stem cell treatment significantly reduced the symptoms of paralysis such as speech impairment, arms and legs paralysis. Patients who were chair bound were able to walk without a walking frame after second treatment.

In addition, some patients' language skills improved by more than 90%. In the case of facial nerve paralysis, after 3 months' treatment, some patients could recover their impairment by 80%. Some patients who had difficulty closing their eyes and speaking due to mouth drooping could close their eyelids to 80% of their normal conditions and the other patients have softened and eased movement of their lips after the treatment. Also, some patient's wrinkles around their mouth were flattened and some patients with dry mouth could facilitate their movement of their faces. All of these improvements in symptoms were achieved with no side effects.

Chairman KYE HO LEE at STC Life said "We have been successfully carrying out stem cell therapy for the various diseases such as Parkinson's disease, autoimmune disorders, anemia, brain disorders, etc. Stem cells collected from STC Life Research Institute are known as adult stem cells that present in the body tissues and organs, thus maintaining the function of normal cells and the regeneration of damaged tissues in the human organs and enabling a variety of growth and differentiation in the human organs."

Source: Business Wire

Click here for the complete issue.

NEWS CRUNCH  
news Accuron Technologies' MedTech Division Invests into AWAK Technologies
news Philips introduces PerformanceBridge suite of operational performance improvement software and services for radiology departments
news Give a Gift that Will Last a Lifetime this Holiday Season with Smile Train
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  

Lady Ganga: Nilza'S Story
COLUMNS  
Subscribe to APBN E-Newsletter
Find us under 'Others' option to receive APBN e-newsletters thrice a month!

APBN Editorial Calendar 2017
January:
Lungs & Respiratory System
February:
Cancer Research, Treatment/Technology
March:
Traditional Chinese Medicines
April:
Eye Care/ Eye Health
May:
The Piece of Your Mind - Brain Health/Science
June:
Featuring Biotech Start-Ups/Companies
July:
Food Science & Technology
August:
Diabetics Technology
September:
No. 1 Killer - Heart Diseases, Diagnosis and Treatment
October:
Skin Diseases/Allergic Reactions
November:
Diseases threatening our Children
December:
Liver Health & Treatment/Technology
Editorial calendar is subjected to changes.
– Editor: Carmen, Jia Wen Loh
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Carmen
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2016 World Scientific Publishing Co Pte Ltd  •  Privacy Policy